Mitsuo Hori

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki et al. · New England Journal of Medicine · 2018 · 526 citations · Full text

Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.

Sadao Yoshida, Takeshi Todoroki, Yoshihito Ichikawa et al. · PubMed · 1995 · 155 citations

Gall Bladder Cancer, Pathology, Cell Cycle +17

Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial

Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki et al. · Journal of Clinical Oncology · 2022 · 105 citations · Full text

Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7

Jiro Kikuchi, Mitsuo Hori, Hidekatsu Iha et al. · Leukemia · 2019 · 66 citations

Cell Interaction, Cell Trafficking, Myeloma Cells +10

Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells

Amuguleng Bai, Hiroshi Kojima, Mitsuo Hori et al. · Experimental Hematology · 1999 · 48 citations

Hematological Malignancy, Myeloid Leukemia Cells, Apoptosis +9